Not sure how advanced AVH and FTT are, the WH-1 drug for Qbiotics is certainly a pipeline cthing but is currently being tested on animals with some great results. It is even provingto be regenerative, and not just wound closing.. think about that... For example one horse it was tested on a while back now grew it's own coloured hair over the closed wound - not grey hair which horses normally do on a wound.
The attraction of Qbiotics to me (even at $120m AUD cap) is the imminent revenue from the veterinary anti-cancer drug. This is a big market that should limit further dilutions into the future. Rick Holliday-Smith now at the helm gives me confidence the nutty scientists will not deviate from this plan.
